DJIA 17,067.56 -30.89 -0.18%
NASDAQ 4,598.19 17.92 0.39%
S&P 500 2,002.28 -1.09 -0.05%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

59.79 -0.32 (-0.53%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $59.79 -0.53%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.73
Previous Close $60.11
Daily Range $59.67 - $60.10
52-Week Range $44.62 - $60.58
Market Cap $172.5B
P/E Ratio 31.64
Dividend (Yield) $1.76 (2.9%)
Ex-Dividend Date
Dividend Pay Date
09/11/14
10/07/14
Volume 6,054,466
Average Daily Volume 7,863,340
Current FY EPS $3.49

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary

This New Novartis AG Drug May Revolutionize Heart Failure Treatment

Novartis LCZ696 may give doctors the first significant high blood pressure drug approved in decades if regulators give it the okay next year.

Regeneron/Sanofi Presents Encouraging Alirocumab Data - Analyst Blog

3 Stocks Reiterated As A Buy: MA, MSFT, MRK

Weekly Pharma Notes: Bristol-Myers Squibb, Pfizer, Merck And Roche

Is It Time to Buy Pfizer Inc.'s Stock?

Pfizer stock has more than doubled since the recession lows. Can its shares head even higher or should investors be looking to lock in their gains?

AMGN, MRK And PFE, 3 Drugs Stocks Pushing The Industry Lower

Top-Yielding Stocks Dominate UBS Equity Focus List for September

Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri

Regeneron Pharmaceuticals and Sanofi's PCSK9 drug, alirocumab, reduces cardiovascular events, but the data come from a post-hoc analysis.

S.Korea lifts ban on beef with feed additive -food ministry

Market View For 2014 And 2015, The Investor's View

See More MRK News...

MRK's Top Competitors

MRK $59.79 (-0.53%)
Current stock: MRK
JNJ $103.36 (-0.36%)
Current stock: JNJ
NVS $93.71 (4.31%)
Current stock: NVS
RHHBY $36.56 (0.14%)
Current stock: RHHBY